Most Claims Survive In Royalty Spat Over HPV Drug
A Delaware judge has let the majority of claims stand in a breach of contract suit brought against MedImmune Inc. and Glaxo Group Ltd. over human papillomavirus vaccine Cervarix, but has...To view the full article, register now.
Already a subscriber? Click here to view full article